These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 5901816
1. [Therapeutic possibilities in progressive muscular dystrophy]. Beckmann R, von Osten V. Dtsch Med Wochenschr; 1966 Jan 21; 91(3):108-16. PubMed ID: 5901816 [No Abstract] [Full Text] [Related]
2. [New aspects of the management of progressive muscular dystrophy]. Tilscher H, Schenk S. Wien Med Wochenschr; 1967 Nov 04; 117(44):1000-2. PubMed ID: 5591872 [No Abstract] [Full Text] [Related]
3. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)]. Ceccarelli A, Leone P, Moretti A. Clin Pediatr (Bologna); 1967 Sep 04; 49(9):468-75. PubMed ID: 5608288 [No Abstract] [Full Text] [Related]
4. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy]. Radu H, Stenzel K, Blücher G, Gödri I. Neurol Psihiatr Neurochir; 1969 Sep 04; 14(5):435-42. PubMed ID: 5380160 [No Abstract] [Full Text] [Related]
5. [Our experience in the treatment of progressive muscular dystrophy]. Buscaino GA. Acta Neurol (Napoli); 1966 Sep 04; 21(2):133-50. PubMed ID: 5961587 [No Abstract] [Full Text] [Related]
6. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials]. Mancini G, Lapi AS, Schwarzenberg TL, Canibus R, Natoli V. Arch Ital Pediatr Pueric; 1968 Sep 04; 26(1):36-46. PubMed ID: 5737311 [No Abstract] [Full Text] [Related]
7. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine]. Radu H, Stenzel K, Migea S, Bordeianu L. Munch Med Wochenschr; 1967 Dec 22; 109(51):2702-5. PubMed ID: 4873261 [No Abstract] [Full Text] [Related]
8. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle. Nakahara M. Arzneimittelforschung; 1965 Jul 22; 15(7):782-5. PubMed ID: 5898681 [No Abstract] [Full Text] [Related]
9. Studies on progressive muscular dystrophy. I. Effects of adenosinetriphosphate and its related compounds on progressive muscular dystrophy. Nakahara M. Arzneimittelforschung; 1965 Jun 22; 15(6):591-5. PubMed ID: 4223122 [No Abstract] [Full Text] [Related]
10. [On the behavior of some serum enzymatic activities in subjects with progressive muscular dystrophy treated with nucleotide and nucleoside substances. II. Malate dehydrogenase, glutamic oxalacetic transaminase and glutamic-pyruvic transaminase activity]. Canani MB, Rea F, Capasso DA. Boll Soc Ital Biol Sper; 1965 Aug 31; 41(16):901-4. PubMed ID: 5880029 [No Abstract] [Full Text] [Related]
17. [Therapy of progressive muscular dystrophy]. Beckmann R. Med Klin; 1971 Aug 06; 66(32):1099. PubMed ID: 5562103 [No Abstract] [Full Text] [Related]
18. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E. Airenne AL, Westermarck T. Med Biol; 1984 Aug 06; 62(2):154. PubMed ID: 6471936 [No Abstract] [Full Text] [Related]
19. Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy. Nakahara M, Yamada S. Arzneimittelforschung; 1967 Jun 06; 17(6):753-6. PubMed ID: 5632380 [No Abstract] [Full Text] [Related]